FindTrial
Sign In

Effectiveness of homoeopathic Medicines in post traumatic stress disorder

Role of individualised homoeopathic medicine in post traumatic stress disorder a single arm pre post clinical trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082066
Enrollment
35
Registered
2025-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F431- Post-traumatic stress disorder (PTSD)

Interventions

Intervention1: Individualised homoeopathic medicine: All patients will be prescribed Individualised Homoeopathic Medicine after detailed case taking per the directions given by Dr C F S Hahnemann in O

Sponsors

Dr Ashutosh das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals between the ages of 18-65 years who met the inclusion criteria for Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) according to the DSM 5 (2013). 2.Patients 18- 65 years of age. 3.Patients who can read & understand either English, Hindi, or Bengali. 4.Patients who are willing to participate in the study and give written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who are on any recreational drugs. 2.Patients who are already taking homoeopathic treatment or other medications for any other chronic disease. 3.Patient suffering from any life-threatening/ Psychiatric/ illness or Immunocompromised state or other significant disease conditions. 4.Patients unwilling to take part, too sick for consultation, not giving consent to join the study. 5.Patients who are pregnant or intend to conceive for the duration of the study. 6.Patients who have had surgery in the past six weeks. 7.Patients who are not willing to maintain their normal lifestyle (like inhibit themselves from alcohol or other things that were advised) during the study. 8.Patients who are on any treatment for PTSD.

Design outcomes

Primary

MeasureTime frame
The response of the patients to the homoeopathic treatment will be observed and improvement will be assessed by the changes in score in PTSD Checklist for DSM-5 (PCL-5).Timepoint: at the baseline and 6 month—

Secondary

MeasureTime frame
The response of the patients to the homoeopathic treatment will be observed and improvement will be assessed by the changes in score in Screen for Posttraumatic Stress Symptoms (SPTSS) for DSM - IV.Timepoint: at the baseline and 6 month—

Countries

India

Contacts

Public ContactDr Syed Afsar Ali

National Institute of Homoeopathy

Dasashutosh291995@gamil.com8972647977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026